Nuvation Bio Inc. Class A Common Stock vs nVent Electric — how do they compare? Nuvation Bio Inc. Class A Common Stock trades at $5.22 (market cap $1.74B), while nVent Electric trades at $166.51 (market cap $26.58B). The key difference: nVent Electric is far larger — about 15.3× Nuvation Bio Inc. Class A Common Stock's market cap, and nVent Electric pays a 0.51% dividend while Nuvation Bio Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Nuvation Bio Inc. Class A Common Stock for 0 Days and nVent Electric for 11 Days on average.
| NUVB | NVT | |
|---|---|---|
Market Cap | $1.74B | $26.58B |
Volume | 9,289,619 | 2,520,678 |
Sector | Health | Industrials |
52-Week High | $9.54 | $184.34 |
52-Week Low | $3.41 | $94.99 |
Typical Hold Time | 0 Days | 11 Days |
Enterprise Value | $1.33B | $27.95B |
Dividend Yield | — | 0.51% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →nVent provides electrical connection and protection solutions, including enclosures, fastening systems, and thermal management products. Its products help support electrical and industrial infrastructure across multiple end markets.
Read more on NVT →